Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongxia Gao

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
The Journal of Pathology. Clinical Research|August 4, 2017
A predictive analysis of the SP120 and 10D7G2 antibodies for human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma treated with adjuvant gemcitabineSteve E Kalloger, Maziar Riazy, Basile Tessier-Cloutier, et al.
Nature Communications|February 17, 2022
Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomesKarama Asleh, Gian Luca Negri, Sandra E Spencer Miko, et al.
International Journal of Cancer|November 10, 2018
Basal biomarkers nestin and INPP4B predict gemcitabine benefit in metastatic breast cancer: Samples from the phase III SBG0102 clinical trialKarama Asleh, Stina Lyck Carstensen, Charlotte L Tykjaer Jørgensen, et al.
Journal of the National Cancer Institute|May 14, 2009
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancerMaggie C U Cheang, Stephen K Chia, David Voduc, et al.
International Journal of Cancer|September 21, 2020
Stroma vs epithelium-enhanced prognostics through histologic stratification in pancreatic ductal adenocarcinomaSteve E Kalloger, Joanna M Karasinska, Martin S Keung, et al.
Cell Metabolism|September 15, 2015
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast CancerFanny Dupuy, Sébastien Tabariès, Sylvia Andrzejewski, et al.
Cancer Immunology Research|May 16, 2019
Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and SystemicallyShawn C Chafe, Paul C McDonald, Saeed Saberi, et al.
Breast Cancer Research and Treatment|February 6, 2016
Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptorBrandon S Sheffield, Zuzana Kos, Karama Asleh-Aburaya, et al.
Breast Cancer Research and Treatment|January 2, 2015
Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trialShuzhen Liu, Judy-Anne W Chapman, Margot J Burnell, et al.
Journal of Cell Science|September 13, 2023
Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cellsPaalini Sathiyaseelan, Suganthi Chittaranjan, Steve E Kalloger, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
The Journal of Pathology. Clinical Research|August 4, 2017
A predictive analysis of the SP120 and 10D7G2 antibodies for human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma treated with adjuvant gemcitabineSteve E Kalloger, Maziar Riazy, Basile Tessier-Cloutier, et al.
Nature Communications|February 17, 2022
Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomesKarama Asleh, Gian Luca Negri, Sandra E Spencer Miko, et al.
International Journal of Cancer|November 10, 2018
Basal biomarkers nestin and INPP4B predict gemcitabine benefit in metastatic breast cancer: Samples from the phase III SBG0102 clinical trialKarama Asleh, Stina Lyck Carstensen, Charlotte L Tykjaer Jørgensen, et al.
Journal of the National Cancer Institute|May 14, 2009
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancerMaggie C U Cheang, Stephen K Chia, David Voduc, et al.
International Journal of Cancer|September 21, 2020
Stroma vs epithelium-enhanced prognostics through histologic stratification in pancreatic ductal adenocarcinomaSteve E Kalloger, Joanna M Karasinska, Martin S Keung, et al.
Cell Metabolism|September 15, 2015
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast CancerFanny Dupuy, Sébastien Tabariès, Sylvia Andrzejewski, et al.
Cancer Immunology Research|May 16, 2019
Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and SystemicallyShawn C Chafe, Paul C McDonald, Saeed Saberi, et al.
Breast Cancer Research and Treatment|February 6, 2016
Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptorBrandon S Sheffield, Zuzana Kos, Karama Asleh-Aburaya, et al.
Breast Cancer Research and Treatment|January 2, 2015
Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trialShuzhen Liu, Judy-Anne W Chapman, Margot J Burnell, et al.
Journal of Cell Science|September 13, 2023
Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cellsPaalini Sathiyaseelan, Suganthi Chittaranjan, Steve E Kalloger, et al.
Pageof 6